SynthesisJAMA network open2020

Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis.

Anders W Erickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.